Updates/Resources on the COVID-19 Vaccine for 5-11 year old's

Posted on November 09, 2021

  • Maine CDC Five Questions for Families Handout
  • MaineCare – Information Sheet on COVID-19 Vaccine for ages 5-17 years. These will be translated and available soon on the MaineCare website.
  • Updated FAQs for aged 5-11 year old are on the Maine Website on COVID-19 vaccines (halfway down the page)
  • The Maine COVID-19 Dashboard now includes 5-11 yr old data
  • MIP Information (11/8/2021) on Pfizer-BioNTech COVID-19 Vaccine: Clinical Materials for Ages 5 Through 11 Years: The U.S. Food and Drug Administration FDA has authorized a COVID-19 vaccine for children 5 through 11 years of age, and CDC’s Advisory Committee on Immunization Practices (ACIP) has new recommendations on vaccinating this population. Below is a list of new clinical materials related to these recommendations:


  • Maine CDC HAN (11/4) Influenza has arrived in Maine. Multiple Maine facilities reported influenza positive rapid results in recent weeks, and Maine’s Health and Environmental Testing Laboratory (HETL) has just confirmed two cases using real-time reverse transcription-polymerase chain reaction (real time-RT PCR) testing. Both specimens tested positive for influenza A/H3. These individuals are adults who were not hospitalized. One patient was unvaccinated, and the vaccine status remains unknown for the other.
  • The Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Update as an update on 11/5/2021 to HAN Update 454: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results that CDC issued on October 14, 2021. The purpose of this HAN Update is to clarify options for retesting children who were tested with the recalled LeadCare lead test kits. The information in this HAN Update remains the same as HAN Update 454, except for the new information added below in bold in the Recommendations for Clinicians section.